Seeker of hope, lover of family; rheumatologist; travel enthusiast. Professor/ Co-Founder/Director of the Johns Hopkins Myositis Center; views are my own
The Global Conference on Myositis in Lisbon was a great week of science, collaboration, and friendship. Our Portuguese colleagues did a magnificent job of welcoming nearly 700 attendees this year. It is clear that we’re finally entering a new era of therapeutics. #GCOM2026
Kudos to my colleague and co-first author @JuliePaikMD on this landmark work. Proud to have contributed to the trial design, including a steroid-sparing protocol and integration of patient-reported outcome measures — more on that to come. DOI: 10.1056/NEJMoa2503531 #Myositis
Delighted to see the VALOR trial, published today in @NEJM: brepocitinib (oral TYK2/JAK1 inhibitor) significantly improved the TIS vs. placebo in treatment-resistant #dermatomyositis (Δ15.3 pts; P<0.001), w/ superiority across all 9 key secondary endpoints — 🧵
@JuliePaikMD Congratulations, Julie. Grateful to be a small part of this story with everyone. It’s a great day and the beginning of a therapeutic era previously unseen in myositis.
Calcinosis is a painful, disfiguring and debilitating complication of SSc and DM. Our study suggests that 18F-NaF PET/CT may have advantages over expert clinical exam or CT alone for detection/quantification of calcinosis. #myositis#ssc#calcinosis
https://t.co/m6o0IKNjmm
Don't miss this fast-paced but deep dive into real-life inclusion body myositis cases, led by @drlisacs + @ElieNaddaf3.
IBM is rare, but the misdiagnoses are common. Get up to speed on what every clinician needs to know! ➡️ https://t.co/kpLV8JYiLw
@ElieNaddaf3 Fewer and fewer whole food healthy choices are available. Current estimates suggest that 73% of the United States food supply is ultra-processed. And highly palatable food (sugar/salt) is very easy to over-eat. This is a public health disaster.